Abstract
Sequential changes in plasma renin activity and urinary aldosterone and noradrenaline were assessed in eight patients with severe hypertension after minoxidil had been added to their treatment. Doses of 2.5--27.5 (mean 12.5) mg/day reduced the mean blood pressure from 166/113 +/-6/2 mm Hg to 124/88+/-4/2 mm Hg in one week. Plasma renin activity and urinary aldosterone and noradrenaline increased twofold to threefold initially but returned to baseline values within two to three weeks and remained unchanged during a mean follow-up of 5.1 months. Beta-blocking drugs were then withdrawn slowly in six patients without adverse effects, though blood pressure and heart rate increased in three patients, who required minimal doses of beta-blockers. Plasma renin activity and urinary aldosterone and noradrenaline did not change significantly after beta-blockade had been stopped. We conclude that the need for beta-blockade is greatly reduced with long-term minoxidil treatment and that it may be unnecessary in some patients.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Assaykeen T. A., Clayton P. L., Goldfien A., Ganong W. F. The effect of alpha- and beta-adrenergic blocking agents on the renin response to hypoglycemia and epinephrine in dogs. Endocrinology. 1970 Dec;87(6):1318–1322. doi: 10.1210/endo-87-6-1318. [DOI] [PubMed] [Google Scholar]
- Davis J. O., Freeman R. H. Mechanisms regulating renin release. Physiol Rev. 1976 Jan;56(1):1–56. doi: 10.1152/physrev.1976.56.1.1. [DOI] [PubMed] [Google Scholar]
- Gilmore E., Weil J., Chidsey C. Treatment of essential hypertension with a new vasodilator in combination with beta-adrenergic blockade. N Engl J Med. 1970 Mar 5;282(10):521–527. doi: 10.1056/NEJM197003052821001. [DOI] [PubMed] [Google Scholar]
- Gottlieb T. B., Katz F. H., Chidsey C. A., 3rd Combined therapy with vasodilator drugs and beta-adrenergic blockade in hypertension. A comparative study of minoxidil and hydralazine. Circulation. 1972 Mar;45(3):571–582. doi: 10.1161/01.cir.45.3.571. [DOI] [PubMed] [Google Scholar]
- Koch-Weser J. Vasodilator drugs in the treatment of hypertension. Arch Intern Med. 1974 Jun;133(6):1017–1027. [PubMed] [Google Scholar]
- Küchel O., Fishman L. M., Liddle G. W., Michelakis A. Effect of diazoxide on plasma renin activity in hypertensive patients. Ann Intern Med. 1967 Oct;67(4):791–799. doi: 10.7326/0003-4819-67-4-791. [DOI] [PubMed] [Google Scholar]
- Limas C. J., Freis E. D. Minoxidil in severe hypertension with renal failure. Effect of its addition to conventional antihypertensive drugs. Am J Cardiol. 1973 Mar;31(3):355–361. doi: 10.1016/0002-9149(73)90268-3. [DOI] [PubMed] [Google Scholar]
- O'Malley K., Velasco M., Wells J., McNay J. L. Control plasma renin activity and changes in sympathetic tone as determinants of minoxidil-induced increase in plasma renin activity. J Clin Invest. 1975 Feb;55(2):230–235. doi: 10.1172/JCI107926. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sealey J. E., Bühler F. R., Laragh J. H., Manning E. L., Brunner H. R. Aldosterone excretion. Physiological variations in man measured by radioimmunoassay or double-isotope dilution. Circ Res. 1972 Sep;31(3):367–378. doi: 10.1161/01.res.31.3.367. [DOI] [PubMed] [Google Scholar]
- Sealey J. E., Gerten-Banes J., Laragh J. H. The renin system: Variations in man measured by radioimmunoassay or bioassay. Kidney Int. 1972 Apr;1(4):240–253. doi: 10.1038/ki.1972.34. [DOI] [PubMed] [Google Scholar]
- Ueda H., Yagi S., Kaneko Y. Hydralazine and plasma renin activity. Arch Intern Med. 1968 Nov;122(5):387–391. [PubMed] [Google Scholar]